Liquid biopsy technology may not be fully mature enough to deliver reliable results , according to two researchers at the Brady Urological Institute at Johns Hopkins . A comparison study to find patients using Guardant360 by Discovery Health and PlasmaSELECT - R64 from Personal ##ity Diagnostics produced results that exactly matched in just three out of 40 patients . Study lead author Gonzalo García said the test demonstrated that " certification for these laboratories must exist " .
Liquid biopsy technology may not be fully mature enough to deliver reliable results, according to two researchers at the Brady Urological Institute at Johns Hopkins. A comparison test to find mutations using Guardant360 by Guardant Health and PlasmaSELECT-R64 from Personal Genome Diagnostics produced results that exactly matched in just three out of 40 patients. Study lead author Gonzalo Torga said the test demonstrated that "certification for these laboratories must improve".